Sleep medicine has a dirty secret: for decades, treatment has been surprisingly one-size-fits-all. Got obstructive sleep apnea? Here’s a CPAP machine. Can’t tolerate CPAP? Try a mandibular advancement device. Still struggling? Maybe surgery. The decision tree is simple, but it doesn’t account for the enormous variability between patients.

That’s starting to change, and artificial intelligence is a big part of the reason.

The Problem With Standard Protocols

Consider two patients with identical AHI scores of 25 — both classified as moderate OSA. Patient A is a 35-year-old woman with a BMI of 23, positional apnea (events mainly when sleeping on her back), and mild symptoms. Patient B is a 58-year-old man with a BMI of 34, events in all positions, significant oxygen desaturation, and untreated hypertension.

Under traditional protocols, both patients get prescribed CPAP at a starting pressure determined by a titration study. But their needs, their likelihood of tolerating treatment, and their risk profiles are vastly different.

What we actually need is a way to process dozens of variables simultaneously — craniofacial anatomy, BMI, comorbidities, arousal threshold, loop gain, airway collapsibility, psychological profile, lifestyle factors — and generate treatment recommendations tailored to the individual. Humans can consider maybe five or six factors at once. Algorithms can handle hundreds.

Where AI Fits In

Several research groups are now applying machine learning to sleep medicine data, and the results are genuinely promising.

Phenotyping sleep apnea. A study from Brigham and Women’s Hospital identified distinct OSA subtypes based on symptom clusters, physiological traits, and comorbidity patterns. AI-driven clustering analysis revealed that patients within the same AHI severity band could have fundamentally different underlying causes — and therefore different optimal treatments.

Predicting treatment response. Machine learning models trained on polysomnography data, patient demographics, and anatomical measurements can now predict with reasonable accuracy whether a patient will respond well to CPAP, an oral appliance, positional therapy, or surgery. This isn’t perfect yet, but it’s considerably better than trial-and-error.

Optimising CPAP settings. Modern auto-titrating CPAP machines already use basic algorithms to adjust pressure throughout the night. Next-generation systems are incorporating more sophisticated AI that learns from individual breathing patterns over weeks and months, fine-tuning pressure delivery in ways that a single-night titration study can’t match.

Tailoring CBT-I. Cognitive Behavioural Therapy for Insomnia (CBT-I) is the gold-standard treatment for chronic insomnia, but it’s traditionally delivered in a fixed format. AI-powered platforms like Sleepio are adapting the therapy in real-time based on patient responses, sleep diary data, and progress metrics. Early results suggest that personalised delivery improves outcomes compared to standardised programs.

The Data Foundation

None of this works without data, and sleep medicine actually generates a lot of it. A single polysomnogram produces hundreds of megabytes of physiological recordings. Home sleep tests, wearable devices, CPAP machines with cloud connectivity — they all generate continuous streams of data that historically went mostly unanalysed.

The shift is toward treating this data as a resource rather than a byproduct. When you aggregate and analyse patterns across thousands of patients, you start to see relationships that individual clinicians can’t detect from their own caseload. Team400 has been working with healthcare organisations on exactly this kind of data infrastructure, building systems that turn raw clinical data into actionable insights.

What This Looks Like in Practice

Imagine walking into a sleep clinic in 2028. Your initial consultation includes standard questionnaires and a physical examination, but it also feeds your data into a decision-support system. That system cross-references your profile against outcomes data from tens of thousands of previous patients with similar characteristics.

Instead of hearing “let’s try CPAP and see how you go,” you might hear: “Based on your anatomy, symptom profile, and the fact that 78% of patients with your characteristics do well on a mandibular advancement device, we’d recommend starting there. Your predicted CPAP adherence is low, but if the oral appliance doesn’t resolve your symptoms adequately, we have good evidence that a combination approach would work for your phenotype.”

That’s precision medicine. It respects the patient’s time, reduces treatment failure, and allocates resources more efficiently.

The Caveats

I want to be clear-eyed about limitations. AI in sleep medicine is still largely in the research phase. Most of the models I’ve described are being validated in academic settings, not deployed in routine clinical care. The gap between “promising study” and “reliable clinical tool” is real and important.

There are also legitimate concerns about data privacy, algorithmic bias (most training datasets skew toward male patients from Western countries), and the risk of over-relying on technology at the expense of clinical judgment.

But the direction is clear. Sleep medicine is moving from population-level guidelines toward individual-level predictions, and AI is the engine making that possible.

Why It Matters for Patients

If you’ve ever been given a treatment that didn’t work and felt like the process was just guesswork — you weren’t wrong. It often is guesswork, educated guesswork, but guesswork nonetheless.

The promise of AI-driven personalisation isn’t about replacing sleep physicians. It’s about giving them better tools so patients spend less time on treatments that were never going to work for them, and more time actually sleeping well.